Ipsen, Skyhawk Therapeutics To Develop RNA-Modulating Molecules For Rare Neurological Disorders

(RTTNews) – French biopharmaceutical company Ipsen SA (IPSEY) and Skyhawk Therapeutics announced an exclusive worldwide collaboration aimed at discovering and developing novel small molecules capable of modulating RNA for rare neurological diseases.

admin